Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Akums Drugs and Pharmaceutical
AKUMS | NSE
553.80
INR-1.70
-0.31%
AKUMS | NSE
Loading StockChartView...
About Akums Drugs and Pharmaceutical
Sector
IN
Industry
IN
Earnings date
01/01/1970
As of date
05/06/2026
Close
553.80
Open
559.50
High
564.90
Low
548.30
View Less
AKUMS | NSE
Risk
26.1
Sharpe
-0.30
Luna's Score
48/100
Recommendation
Hold
Luna says (AKUMS | NSE)
What's Working
Positive Momentum
What's not Working
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
22.3%1 month
26.1%3 months
38.8%6 months
33.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
10.40K
Fwd. PE
-
Price to book
18.53
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
102.76
Ent. to rev.
3.34
PEG
-
Other Fundamentals
EBITDA
4.96B
MarketCap
79.67B
MarketCap(USD)
839.20M
Div. yield
-
Op. margin
8.84
Erngs. growth
-
Rev. growth
5.10
Ret. on equity
-
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
57.80
Range1M
72.65
Range3M
116.15
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.36
Price X volume
53.18M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 102.76 | 38.27 | Expensive |
| Ent. to Revenue | 3.34 | 10.34 | Cheaper |
| PE Ratio | 10,396.90 | 60.68 | Expensive |
| Price to Book | 18.53 | 9.15 | Expensive |
| Dividend Yield | - | 0.66 | - |
| Std. Deviation (3M) | 38.81 | 43.73 | Par |
| Debt to Equity | - | 0.59 | - |
| Debt to Assets | - | 0.20 | - |
| Market Cap | 79.67B | 104.65B | Emerging |
